ProSensa Holding N.V. (RNA) Announces Full Year 2013 Financial Results And Recent Corporate Developments
3/18/2014 9:01:23 AM
LEIDEN, The Netherlands, March 18, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (Nasdaq:RNA), the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, today reported financial results for the full year ending December 31, 2013, and provided an update on the next steps for its exon-skipping platform for the treatment of Duchenne Muscular Dystrophy (DMD).
Help employers find you! Check out all the jobs and post your resume.
comments powered by